Abbott Laboratories
ABT137.400USD
-0.680-0.49%
終値 06/25, 16:00（ET）15分遅れの株価
239.05B時価総額
17.84直近12ヶ月PER
詳細情報 Abbott Laboratories 企業名
Abbott Laboratories is a global healthcare company. The Company’s principal business is the discovery, development, manufacture, and sale of a broad and diversified line of healthcare products. Its segments include Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. Established Pharmaceutical Products segment is engaged in the international sales of a broad line of branded generic pharmaceutical products. Diagnostic Products segment is involved in the worldwide sales of diagnostic systems and tests for blood banks, hospitals, commercial laboratories and alternate-care testing sites. Nutritional Products segment is engaged in the worldwide sales of a broad line of adult and pediatric nutritional products. Medical Devices segment is involved in the worldwide sales of rhythm management, electrophysiology, heart failure, vascular, structural heart, neuromodulation and diabetes care products. It serves people in more than 160 countries.
企業情報
企業コードABT
会社名Abbott Laboratories
上場日Mar 01, 1937
設立日1900
最高経営責任者「CEO」Mr. Robert B. Ford
従業員数114000
証券種類Ordinary Share
決算期末Mar 01
本社所在地100 Abbott Park Road
都市ABBOTT PARK
証券取引所NYSE Consolidated
国United States of America
郵便番号60064-3500
電話番号12246676100
ウェブサイトhttps://www.abbott.com
企業コードABT
上場日Mar 01, 1937
設立日1900
役員一覧
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Daniel J. Starks
Mr. Daniel J. Starks
Independent Director
Independent Director
6.73M
+0.02%
Mr. Hubert L. Allen
Mr. Hubert L. Allen
Executive Vice President, General Counsel, Secretary
Executive Vice President, General Counsel, Secretary
191.90K
+3.84%
Mr. Daniel Gesua Sive Salvadori
Mr. Daniel Gesua Sive Salvadori
Executive Vice President, Group President - Established Pharmaceuticals and Nutritional Products
Executive Vice President, Group President - Established Pharmaceuticals and Nutritional Products
133.77K
+6.42%
Ms. Mary K. Moreland
Ms. Mary K. Moreland
Executive Vice President - Human Resources
Executive Vice President - Human Resources
95.58K
-0.82%
Ms. Lisa D. Earnhardt
Ms. Lisa D. Earnhardt
Executive Vice President, Group President - Medical Devices
Executive Vice President, Group President - Medical Devices
71.93K
--
Mr. Louis H. (Lou) Morrone
Mr. Louis H. (Lou) Morrone
Executive Vice President - Core Diagnostics
Executive Vice President - Core Diagnostics
66.88K
-1.63%
Mr. Philip P. Boudreau
Mr. Philip P. Boudreau
Chief Financial Officer, Executive Vice President - Finance
Chief Financial Officer, Executive Vice President - Finance
56.91K
+44.72%
Dr. Robert J. Alpern, M.D.
Dr. Robert J. Alpern, M.D.
Independent Director
Independent Director
40.80K
+4.17%
Ms. Nancy Mckinstry
Ms. Nancy Mckinstry
Lead Independent Director
Lead Independent Director
38.72K
+4.41%
Ms. Sally E. Blount, Ph.D.
Ms. Sally E. Blount, Ph.D.
Independent Director
Independent Director
34.06K
-2.76%
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Daniel J. Starks
Mr. Daniel J. Starks
Independent Director
Independent Director
6.73M
+0.02%
Mr. Hubert L. Allen
Mr. Hubert L. Allen
Executive Vice President, General Counsel, Secretary
Executive Vice President, General Counsel, Secretary
191.90K
+3.84%
Mr. Daniel Gesua Sive Salvadori
Mr. Daniel Gesua Sive Salvadori
Executive Vice President, Group President - Established Pharmaceuticals and Nutritional Products
Executive Vice President, Group President - Established Pharmaceuticals and Nutritional Products
133.77K
+6.42%
Ms. Mary K. Moreland
Ms. Mary K. Moreland
Executive Vice President - Human Resources
Executive Vice President - Human Resources
95.58K
-0.82%
Ms. Lisa D. Earnhardt
Ms. Lisa D. Earnhardt
Executive Vice President, Group President - Medical Devices
Executive Vice President, Group President - Medical Devices
71.93K
--
Mr. Louis H. (Lou) Morrone
Mr. Louis H. (Lou) Morrone
Executive Vice President - Core Diagnostics
Executive Vice President - Core Diagnostics
66.88K
-1.63%
収益内訳
通貨: USD更新時刻: Sun, Apr 6
通貨: USD更新時刻: Sun, Apr 6
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
事業別USD
会社名
収益
比率
Diabetes Care
6.80B
16.22%
Core Laboratory
5.24B
12.48%
Adult Nutritionals
4.39B
10.46%
Pediatric Nutritionals
4.02B
9.59%
Key Emerging Markets
3.86B
9.20%
Other
17.64B
42.05%
地域別USD
会社名
収益
比率
United States
16.32B
38.91%
All other Countries
14.85B
35.39%
Germany
2.54B
6.05%
China
2.11B
5.04%
India
1.82B
4.33%
Other
4.31B
10.28%
事業別
地域別
事業別USD
会社名
収益
比率
Diabetes Care
6.80B
16.22%
Core Laboratory
5.24B
12.48%
Adult Nutritionals
4.39B
10.46%
Pediatric Nutritionals
4.02B
9.59%
Key Emerging Markets
3.86B
9.20%
Other
17.64B
42.05%
株主
更新時刻: Fri, May 16
更新時刻: Fri, May 16
株主統計
種類
株主統計
株主統計
比率
The Vanguard Group, Inc.
9.72%
BlackRock Institutional Trust Company, N.A.
5.05%
State Street Global Advisors (US)
4.46%
Capital International Investors
3.84%
Capital Research Global Investors
2.92%
Other
74.01%
株主統計
株主統計
比率
The Vanguard Group, Inc.
9.72%
BlackRock Institutional Trust Company, N.A.
5.05%
State Street Global Advisors (US)
4.46%
Capital International Investors
3.84%
Capital Research Global Investors
2.92%
Other
74.01%
種類
株主統計
比率
Investment Advisor
36.36%
Investment Advisor/Hedge Fund
32.77%
Research Firm
3.66%
Pension Fund
2.29%
Bank and Trust
2.24%
Sovereign Wealth Fund
1.32%
Insurance Company
1.08%
Hedge Fund
0.53%
Individual Investor
0.48%
Other
19.27%
機関投資家保有株
更新時刻: Sun, Jan 19
更新時刻: Sun, Jan 19
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q1
4562
1.39B
80.14%
+12.65M
2024Q4
4535
1.39B
80.22%
+15.89M
2024Q3
4391
1.36B
78.29%
-11.85M
2024Q2
4400
1.36B
78.24%
-7.03M
2024Q1
4402
1.35B
77.67%
-9.71M
2023Q4
4429
1.35B
77.56%
-11.05M
2023Q3
4298
1.34B
77.39%
-25.33M
2023Q2
4297
1.35B
77.60%
-13.55M
2023Q1
4281
1.35B
77.46%
-8.61M
2022Q4
4258
1.34B
76.84%
-15.37M
詳細を見る
株主動向
会社名
保有株式数
比率
変動額
変動率
日付
The Vanguard Group, Inc.
167.89M
9.68%
+762.54K
+0.46%
Dec 31, 2024
BlackRock Institutional Trust Company, N.A.
87.07M
5.02%
+811.85K
+0.94%
Dec 31, 2024
State Street Global Advisors (US)
77.17M
4.45%
+447.25K
+0.58%
Dec 31, 2024
Capital International Investors
67.97M
3.92%
+2.23M
+3.39%
Dec 31, 2024
Capital Research Global Investors
54.10M
3.12%
+795.07K
+1.49%
Dec 31, 2024
Geode Capital Management, L.L.C.
35.67M
2.06%
+765.64K
+2.19%
Dec 31, 2024
Wellington Management Company, LLP
26.39M
1.52%
+581.33K
+2.25%
Dec 31, 2024
JP Morgan Asset Management
25.13M
1.45%
+5.11M
+25.51%
Dec 31, 2024
Norges Bank Investment Management (NBIM)
20.98M
1.21%
+626.72K
+3.08%
Dec 31, 2024
Wells Fargo Advisors
15.25M
0.88%
-105.40K
-0.69%
Dec 31, 2024
詳細を見る
関連ETF
更新時刻: Fri, Jun 6
更新時刻: Fri, Jun 6
銘柄名
比率
iShares U.S. Medical Devices ETF
19.21%
Goldman Sachs Future Health Care Equity ETF
5.28%
NYLI Healthy Hearts ETF
5.2%
Invesco Pharmaceuticals ETF
5.17%
Strategas Macro Momentum ETF
4.97%
AdvisorShares Focused Equity ETF
4.64%
Polen Capital Global Growth ETF
4.64%
Health Care Select Sector SPDR Fund
4.53%
Proshares Ultra Health Care
4.38%
iShares U.S. Healthcare ETF
4.32%
詳細を見る
iShares U.S. Medical Devices ETF
比率19.21%
Goldman Sachs Future Health Care Equity ETF
比率5.28%
NYLI Healthy Hearts ETF
比率5.2%
Invesco Pharmaceuticals ETF
比率5.17%
Strategas Macro Momentum ETF
比率4.97%
AdvisorShares Focused Equity ETF
比率4.64%
Polen Capital Global Growth ETF
比率4.64%
Health Care Select Sector SPDR Fund
比率4.53%
Proshares Ultra Health Care
比率4.38%
iShares U.S. Healthcare ETF
比率4.32%
配当金
過去5年間の配当金総支払額は
16.46B
米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
Dec 13, 2024
ABT.NB Interim Cash Dividend of gross USD 0.59 paid on Feb 14, 2025 going ex on Jan 15, 2025 with reinvestment option
Jan 15, 2025
Feb 14, 2025
Jan 15, 2025
Sep 19, 2024
ABT.NB Final Cash Dividend of gross USD 0.55 paid on Nov 15, 2024 going ex on Oct 15, 2024
Oct 15, 2024
Nov 15, 2024
Oct 15, 2024
Jun 15, 2024
ABT.NB Interim Cash Dividend of gross USD 0.55 paid on Aug 15, 2024 going ex on Jul 15, 2024 with reinvestment option
Jul 15, 2024
Aug 15, 2024
Jul 15, 2024
Feb 16, 2024
ABT.NB Interim Cash Dividend of gross USD 0.55 paid on May 15, 2024 going ex on Apr 12, 2024
Apr 15, 2024
May 15, 2024
Apr 12, 2024
Dec 15, 2023
ABT.NB Interim Cash Dividend of gross USD 0.55 paid on Feb 15, 2024 going ex on Jan 11, 2024 with reinvestment option
Jan 12, 2024
Feb 15, 2024
Jan 11, 2024
Sep 21, 2023
ABT.NB Final Cash Dividend of gross USD 0.51 paid on Nov 15, 2023 going ex on Oct 12, 2023 with reinvestment option
Oct 13, 2023
Nov 15, 2023
Oct 12, 2023
Jun 09, 2023
ABT.NB Interim Cash Dividend of gross USD 0.51 paid on Aug 15, 2023 going ex on Jul 13, 2023 with reinvestment option
Jul 14, 2023
Aug 15, 2023
Jul 13, 2023
Feb 17, 2023
ABT.NB Interim Cash Dividend of gross USD 0.51 paid on May 15, 2023 going ex on Apr 13, 2023 with reinvestment option
Apr 14, 2023
May 15, 2023
Apr 13, 2023
Dec 09, 2022
ABT.NB Interim Cash Dividend of gross USD 0.51 paid on Feb 15, 2023 going ex on Jan 12, 2023 with reinvestment option
Jan 13, 2023
Feb 15, 2023
Jan 12, 2023
Sep 15, 2022
ABT.NB Final Cash Dividend of gross USD 0.47 paid on Nov 15, 2022 going ex on Oct 13, 2022 with reinvestment option
Oct 14, 2022
Nov 15, 2022
Oct 13, 2022
詳細を見る
株式分割
日付
種類
比率
データなし
日付
種類
比率
データなし
